Affiliation:
1. University of Kragujevac , Serbia , Faculty of Medical Sciences, Department of Pharmacy
2. University of Kragujevac , Serbia , Faculty of Medical Sciences, Department of Pharmacology and Toxicology
3. University of Kragujevac , Serbia , Faculty of Medical Sciences, Department of Surgery
Abstract
Abstract
Background: Drug-drug interactions are defined as modifications of the drug action that result from the simultaneous administration of another individual drug or several drugs. Nowadays, potential drug-drug interactions (DDIs) are most frequently detected and analyzed using personal digital assistant software programs (online interaction checker tools).
Objective: To determine the risk factors for the emergence of all drug-drug interactions in surgical patients with particular emphasis on clinically significant interactions.
Patients and methods: This was a retrospective cohort analysis of patients treated at the Surgical Clinic of the Clinical Center Kragujevac. Three interaction checkers were used to reveal drug-drug interactions: Medscape, Epocrates and Micromedex.
Results: The study included total of 200 patients, aged 58.54±17.08 years. Average number of drug-drug interactions per patient was between 10.50±9.10 (Micromedex) and 18.75±17.14 (Epocrates). Number of prescribed drugs, antidepressive therapy, antiarrhythmic therapy, number of pharmacological/therapeutic subgroups (2nd level of ATC classification) prescribed, delirium or dementia, diabetes, heart failure, and number of physicians who prescribed drugs to single patient were identified as risk factors for drug-drug interactions while length of hospitalization in days and age of patient in years emerged as protective factors.
Conclusion: Drug-drug interactions are relatively common in surgical patients and predisposed by factors such as number of prescribed drugs or drug group per patient, number of physicians who prescribed drugs, antidepressive therapy, antiarrhythmic therapy, presence of delirium or dementia, diabetes and heart failure. On the other hand, prolonged hospitalization and higher age are factors that reduce the risk of interactions in surgical patients.
Reference38 articles.
1. 1. May JR, DiPiro JT, Sisley JF. (1987). Drug interactions in surgical patients. Am J Surg, 153(3):327-35.
2. 2. Hasan SS, Lim KN, Anwar M, et al. (2012). Impact of pharmacists' intervention on identification and management of drug-drug interactions in an intensive care setting. Singapore Med J, 53(8):526-31.
3. 3. Janković SM, Pejčić AV, Milosavljević MN, et al. (2018). Risk factors for potential drug-drug interactions in intensive care unit patients. J Crit Care, 43:1-6.
4. 4. Kheshti R, Aalipour M, Namazi S. (2016). A comparison of five common drug-drug interaction software programs regarding accuracy and comprehensiveness. J Res Pharm Pract, 5(4):257-263.
5. 5. Truven Health Analtytics LLC, Micromedex® Solutions,https://www.micromedexsolutions.com/home/dispatch/PFDefaultActionId/pf.LoginAction/ssl/true?redirected=true; 2019 [accessed 20.03.2019].
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献